Medical Marijuana, Inc. Subsidiary HempMeds® Announces Participation at Natural Products Expo East

SAN DIEGO, Sept.11, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, subsidiary HempMeds® announced today that it will be attending and exhibiting at Natural Products Expo East in Baltimore, Maryland on September 12-15, 2018.

According to the Nutrition Business Journal, the U.S. natural products industry made more than $200 billion in revenue in 2017. The Hemp Business Journal reported earlier this year that the U.S. cannabidiol (CBD) market grew 16% and made over $820 million in 2017.

At the event, HempMeds® will be sponsoring a booth to exhibit the company’s portfolio of trusted and reputable CBD products. Medical Marijuana, Inc. Chief Executive Officer Dr. Stuart Titus will also be in attendance and available to connect with other industry leaders to educate them on the benefits of CBD.

“We are thrilled to have a booth at this year’s Natural Products Expo East,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “Events like these allow us to increase the public and other businesses’ knowledge of the benefits of cannabidiol and our product lines, especially as legal cannabis market grows exponentially in the U.S.”

Natural Products Expo East, hosted at Baltimore Convention Center, aims to connect retailers, wholesalers and producers from across the natural products industry. The three-day exhibition will not only feature numerous companies within the natural products landscape, but also offer programming that includes workshops, demos, speakers, education sessions and more.

HempMeds® was the first company to ever bring hemp-based cannabidiol (CBD) oil products to market in the U.S. in 2012 — and the first to both make CBD products available in bulk for U.S. consumers and also provide high-quality CBD hemp oil to customers around the world. HempMeds® was also the first-ever company to receive historic federal government import approvals for its CBD products in the nations of Argentina, Brazil, Mexico and Paraguay. making fake id are the cards advertised as copying a real ID card. The examining machines can filter yet will not recognize the genuine and counterfeit. Be that as it may, the data imprinted on the card doesn’t match the first card, distinguishing it as a phony id. To perceive a phony id card, one should look cautiously into the first page and rear card. In the event that it doesn’t coordinate, then, at that point, the card is phony.

Visit HempMeds® at booth #3200 and contact [email protected] to schedule an on-site interview with Medical Marijuana, Inc. CEO Dr. Stuart Titus.

About HempMeds®

HempMeds® is a corporate portfolio company of Medical Marijuana, Inc. (OTC:MJNA) and the Company’s exclusive master distributor and contracted marketing company, handling sales and distribution.

About Medical Marijuana, Inc.

We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit

To see Medical Marijuana, Inc.’s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.


These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.


Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.


Public Relations Contact:

Andrew Hard

Chief Executive Officer, CMW Media

P. 858-264-6600

[email protected]